BIOMAT Database Logo BIOMAT Database Logo

Variations in HIV-RNA viral load and CD4 counts of infants and children receiving antiretroviral drug therapy. 1999

J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Distribution of HIV-1 plasma RNA viral load and CD4 + T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy.
September 2001, Journal of acquired immune deficiency syndromes (1999),
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy.
August 1999, AIDS (London, England),
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
[Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load].
March 2018, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Nutritional status and CD4 cell counts in patients with HIV/AIDS receiving antiretroviral therapy.
January 2013, Revista da Sociedade Brasileira de Medicina Tropical,
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
November 2017, Journal of acquired immune deficiency syndromes (1999),
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
November 2001, JAMA,
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Changes of Viral Load, Drug Resistance, and CD4 Cell Count in HIV-1-Infected Patients Receiving Antiretroviral Therapy in Hebei Province, China, 2003-2019.
October 2023, AIDS research and human retroviruses,
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
[Correlation between CD4 T-cell counts and HIV-1 RNA plasma levels in HIV-1 patients receiving highly active antiretroviral therapy (HAART)]
January 1999, Le infezioni in medicina,
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
July 2003, AIDS (London, England),
J L Sever, and T A Rakusan, and B Loechelt, and T Schutzbank, and S Zamer, and R O'Donnell, and M V Price
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life.
February 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!